Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2008
12/31/2008WO2009002829A2 Tableted compositions containing atazanavir
12/31/2008WO2009002826A2 Tableted compositions containing atazanavir
12/31/2008WO2009002823A2 Tableted compositions containing atazanavir
12/31/2008WO2009002821A2 Tableted compositions containing atazanavir
12/31/2008WO2009001942A1 Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound, and method for production of isoxazoline compound
12/31/2008WO2009001784A1 N-phenyl-methanamine derivative and pest control agent containing the same
12/31/2008WO2009001730A1 Novel compound having β secretase inhibitory activity
12/31/2008WO2009000864A1 Novel polyhydroxylated compounds as fatty acid synthase (fasn) inhibitors
12/31/2008WO2009000753A1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
12/31/2008WO2008140066A3 Pyridone derivatives as p38a mapk inhibitors
12/31/2008WO2008082487A3 Novel jnk inhibitors
12/31/2008WO2008059551A3 Process for the preparation of imatinib and intermediates thereof
12/31/2008EP2009001A1 Method for manufacturing dioxazine derivatives
12/31/2008EP2007745A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
12/31/2008EP2007726A2 Benzamide and heteroarene derivatives as cetp inhibitors
12/31/2008EP2007720A1 Benzamide derivatives as inhibitors of histone deacetylase
12/31/2008EP2007717A1 Novel sulfonamide compounds
12/31/2008EP2007714A2 Orally bioavailable caffeic acid related anticancer drugs
12/31/2008EP2007707A1 Compounds which modulate the cb2 receptor
12/31/2008EP1730203B1 Catalyst composition and use thereof
12/31/2008EP1542974B1 5-[((2,3-difluorophenyl)methyl)thio]-7-{[(1S,2S)-2-hydroxy-1-(hydroxymethyl)propyl]amino}thiazolo[4,5-d]pyrimidin-2(3H)-one as CXCR2 antagonist
12/31/2008EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
12/31/2008CN101336238A Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
12/31/2008CN101333188A Polymers and oligomers, their synthesis, and electronic devices incorporating same
12/31/2008CN101333187A Novel PI3K enzyme inhibitors and uses thereof
12/31/2008CN101333184A Processes for the preparation of (r)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4 piperidinemethanol
12/31/2008CN100447137C P-38 kinase inhibitors
12/31/2008CN100447134C In-situ treatment of pyridine-2,3-dicarboxylic acid esters with an oxidizing agent
12/31/2008CN100447133C Process for preparing symmetric tetrachloro pyridine
12/31/2008CA2693226A1 New compounds with antithrombin function and pharmaceutical compositions on their basis
12/31/2008CA2692363A1 New anticoagulant compounds, pharmaceutical compositions comprising these compounds for treatment of thrombotic states, and plasma-substituting solutions to correct hypercoagulation defects of hemodilution
12/31/2008CA2691772A1 Crystalline polymorph of exemestane
12/31/2008CA2690191A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/31/2008CA2690145A1 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin
12/30/2008US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470791 reacting an anion of 4-amino-3,5-dichloropyridine containing potassium cation with an activated derivative of 3-cyclopropylmethoxy-4-difluoromethoxybenzoic acid in a solvent selected from dimethylformamide or N-methylpyrrolidone; potassium tert-butoxide is used to prepare the amine salt; intermediate
12/30/2008US7470702 Benzimidazoles
12/30/2008US7470701 e.g. 3-(4-fluorophenyl)-N-{5-[2-(methylamino)pyrimidin-4-yl]thien-2-yl}propanamide; PKB/Akt kinase inhibitor; anticarcinogenic agent; carcinoma, cancer metastases, squamous cell carcinoma, esophageal squamous cell carcinoma, oral carcinoma, cutaneous T cell lymphoma, Hodgkin's lymphoma
12/30/2008CA2223720C Novel uses for thyroid hormones or thyroid hormone-like compounds
12/30/2008CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
12/30/2008CA2178062C Improved process for the manufacture of 5-(alkoxymethyl)pyridine-2,3-dicarboxylate salt
12/25/2008US20080319188 Novel pyridine derivatives and pyrimidine derivatives (3)
12/25/2008US20080319028 Dicycloalkylcarbamoyl Ureas As Glucokinase Activators
12/25/2008US20080319026 Substituted n-aryl pyridinones
12/25/2008US20080318976 Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists
12/25/2008US20080318958 New utilities of tricyclic compounds
12/25/2008US20080318956 Inflammatory cytokine release inhibitor
12/25/2008US20080318923 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle
12/25/2008US20080317839 Amino acid lipids and uses thereof
12/24/2008WO2008157786A1 Substituted n-aryl pyridinones as fibrotic inhibitors
12/24/2008WO2008157234A2 Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors
12/24/2008WO2008156632A1 Azapeptide derivatives
12/24/2008WO2008156573A1 Kinase inhibitors, compositions thereof, and methods of use therewith
12/24/2008WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
12/24/2008WO2008155004A1 Method for producing dioxazine derivatives
12/24/2008WO2008154905A2 Modifications of the histone deacetylase inhibitor suberoylanilide hydroxamic acid
12/24/2008WO2008124097A3 Salts of isophosphoramide mustard and analogs thereof
12/24/2008WO2008033455A3 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
12/24/2008EP2004619A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
12/24/2008EP2004607A2 New compounds
12/24/2008EP2004606A1 Substituted enaminocarbonyl compounds
12/24/2008EP2004596A2 Compositions useful as inhibitors of voltage-gated sodium channels
12/24/2008EP2004595A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
12/24/2008EP2004166A2 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
12/24/2008EP1620102B1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
12/24/2008DE69922977C5 Neue Kristallmodifikation von Torasemid New crystal modification of torasemide
12/24/2008CN101331145A Metal complex compound and organic electroluminescent device using same
12/24/2008CN101331124A Novel vanilloid receptor ligands and their use for producing medicaments
12/24/2008CN101331114A 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
12/24/2008CN101330831A Bactericidal composition comprising carboxylic acid amide derivative
12/24/2008CN101328152A Piperazidine compound and pyridine compound
12/24/2008CN101328135A Carbonyl phenyl propanoic acid derivative compounds
12/24/2008CN101327452A Salen metallic catalyst and preparation method
12/24/2008CN100445294C Platinum complex and luminescent element
12/24/2008CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/24/2008CN100444839C Treatment of chemokine mediated diseases
12/24/2008CA2692028A1 Azapeptide derivatives
12/24/2008CA2691379A1 Substituted n-aryl pyridinones
12/24/2008CA2690410A1 Kinase inhibitors, compositions thereof, and methods of use therewith
12/24/2008CA2690357A1 Bifunctional synthetic molecules
12/23/2008US7468437 useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P; treatment of certain disorders, including emesis, depression, and anxiety
12/23/2008US7468393 Diarylsulfones as 5-HT2A antagonists
12/23/2008US7468383 Proteasome inhibitors and methods of using the same
12/23/2008US7468382 useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC-theta, including immunological disorders and type II diabetes
12/23/2008US7468375 Inhibitors of the HIV integrase enzyme
12/23/2008US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression;
12/23/2008US7468212 Organic electroluminescent device
12/23/2008CA2424664C Novel non-imidazole compounds
12/23/2008CA2360676C A method for treating patients with acne by administering a cyclic gmp pde inhibitor
12/23/2008CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity
12/18/2008WO2008154642A2 Antibacterial agents
12/18/2008WO2008154484A1 Ire-1a inhibitors
12/18/2008WO2008154372A1 Mutual prodrugs and methods to treat cancer
12/18/2008WO2008130321A3 Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain
12/18/2008WO2008130320A3 Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
12/18/2008WO2008116139A3 N-heterocyclic compounds useful as inhibitors of janus kinases
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008WO2008102127A3 Gel forming compounds
12/18/2008WO2008043072A3 Cd80 antagonists for treating neoplastic disorders
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 633